GleamWall
中文EN

SGRY Surgery Partners, Inc.

Services-General Medical & Surgical Hospitals, NEC · Nasdaq · SEC CIK 1638833 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.2%
TTM net income YoY49.2%
TTM EPS YoY50.7%
Revenue 3-yr CAGR7.4%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin10.8%
Net margin-2.6%
FCF margin6.0%
EBITDA margin16.1%

Returns

ROE-5.1%
ROA-1.2%
ROIC (approx.)6.1%
Asset turnover0.45x

Leverage & solvency

Liabilities / assets53.8%
Debt / equity1.84x
Current ratio2.17x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-3.19x
Accruals ratio-4.9%
Payout ratio—
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$815.30M$848.90M$810.90M$885.00M$821.50M$826.20M$776.00M$864.40M
SG&A expense$40.60M$36.30M$39.30M$23.70M$22.40M$36.10M$36.00M$36.00M
Operating income$85.60M$102.10M$65.80M$110.20M$105.70M$111.70M$61.90M$127.10M
Pretax income$17.70M$32.30M-$3.30M$42.60M$30.80M$43.80M-$300,000$74.20M
Income tax$3.60M$2.60M-$1.20M$13.60M$5.50M-$1.10M$0$120.80M
Net income-$21.10M-$15.00M-$35.90M-$15.00M-$22.70M-$2.50M-$37.70M-$108.50M
EBITDA$125.20M$141.40M$104.30M$170.10M$145.20M$152.00M$98.20M$161.00M
EPS (basic)-0.16-0.12-0.28—-0.18-0.02-0.30—
EPS (diluted)-0.16-0.12-0.28—-0.18-0.02-0.30—
Weighted avg. shares (diluted)128.87M128.82M128.37M—127.21M126.98M126.60M—
Balance sheet
Cash & equivalents$354.50M$216.70M$182.30M$239.90M$203.40M$250.10M$229.30M$269.50M
Receivables$468.10M$616.60M$603.40M$602.20M$579.30M$563.10M$570.60M$579.10M
Inventory$77.50M$98.80M$100.50M$96.60M$92.30M$87.30M$88.10M$88.40M
Current assets$1.08B$1.13B$1.08B$1.15B$1.10B$1.11B$1.07B$1.12B
PP&E, net$840.60M$1.12B$1.13B$1.15B$1.16B$1.18B$1.15B$1.09B
Goodwill$4.61B$5.20B$5.21B$5.19B$5.09B$5.10B$5.13B$5.07B
Intangibles———$41.00M———$45.70M
Total assets$7.05B$8.05B$8.04B$8.12B$7.95B$7.95B$7.95B$7.89B
Current liabilities$498.60M$578.50M$581.70M$615.50M$586.00M$573.30M$569.40M$624.40M
Short-term debt$56.50M$102.90M$100.40M$99.30M$103.00M$110.00M$103.90M$101.40M
Long-term debt$3.00B$3.65B$3.61B$3.60B$3.46B$3.47B$3.45B$3.27B
Total debt$3.06B$3.75B$3.71B$3.70B$3.56B$3.58B$3.55B$3.37B
Total liabilities$3.79B$4.58B$4.56B$4.59B$4.39B$4.38B$4.36B$4.25B
Shareholders' equity$1.66B$1.67B$1.69B$1.71B$1.73B$1.75B$1.74B$1.79B
Net debt$2.70B$3.53B$3.53B$3.46B$3.36B$3.33B$3.32B$3.10B
Shares outstanding130.86M130.89M130.80M129.32M129.02M128.21M128.19M127.11M
Cash flow statement
Operating cash flow$103.50M$59.30M$11.70M$103.40M$83.60M$81.30M$6.00M$111.40M
Capital expenditure$24.50M$21.80M$16.00M$12.80M$19.80M$23.40M$22.70M$22.30M
Free cash flow$79.00M$37.50M-$4.30M$90.60M$63.80M$57.90M-$16.70M$89.10M
Investing cash flow$468.00M-$19.80M-$13.40M-$126.10M-$46.20M$2.10M-$76.40M-$111.70M
Financing cash flow-$433.70M-$5.10M-$55.90M$59.20M-$84.10M-$62.60M$30.20M$48.00M
Depreciation & amortization$39.60M$39.30M$38.50M$59.90M$39.50M$40.30M$36.30M$33.90M
Stock-based compensation$6.00M$3.80M$5.80M-$2.20M$2.60M$6.80M$7.60M$6.20M

Free plan shows the latest 8 periods; Pro shows all 50 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.